Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma

Published:2019-12-12 Issue:3 Volume:9 Page:1152-1160
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Eckel‐Passow Jeanette E.¹^ORCID,Ho Thai H.²^ORCID,Serie Daniel J.³,Cheville John C.⁴,Houston Thompson R.⁵,Costello Brian A.⁵,Dong Haidong⁵,Kwon Eugene D.⁵,Leibovich Bradley C.⁵,Parker Alexander S.³

Affiliation:

1. Division of Biomedical Statistics and Informatics Mayo Clinic Rochester MN USA

2. Division of Hematology and Medical Oncology Mayo Clinic Scottsdale AZ USA

3. Department of Health Sciences Research Mayo Clinic Jacksonville FL USA

4. Laboratory Medicine and Pathology Mayo Clinic Rochester MN USA

5. Department of Urology Mayo Clinic Rochester MN USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2769

Reference15 articles.

1. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

2. Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

3. Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers

4. The Identification of Immunological Biomarkers in Kidney Cancers

5. Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives;Molecular Cancer;2024-07-16

2. The association between PD-1 / PD-L1 expression and clinicopathological features in sarcomatoid renal cell carcinoma;Asian Journal of Surgery;2024-01

3. Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma;BJU International;2023-08-10

4. A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma;The Journal of Immunology;2023-05-10

5. Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities;The Oncologist;2023-02-06